171 related articles for article (PubMed ID: 23435670)
1. Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?
Takaki A; Yagi T; Yasunaka T; Sadamori H; Shinoura S; Umeda Y; Yoshida R; Sato D; Nobuoka D; Utsumi M; Yasuda Y; Nakayama E; Miyake Y; Ikeda F; Shiraha H; Nouso K; Fujiwara T; Yamamoto K
J Gastroenterol; 2013 Dec; 48(12):1373-83. PubMed ID: 23435670
[TBL] [Abstract][Full Text] [Related]
2. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
3. Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation.
Ikeda A; Takaki A; Yasunaka T; Oyama A; Adachi T; Wada N; Onishi H; Ikeda F; Shiraha H; Yoshida K; Kuise T; Nobuoka D; Yoshida R; Umeda Y; Yagi T; Fujiwara T; Okada H
Acta Med Okayama; 2019 Feb; 73(1):41-50. PubMed ID: 30820053
[TBL] [Abstract][Full Text] [Related]
4. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
6. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
Holt D; Thomas R; Van Thiel D; Brems JJ
Arch Surg; 2002 May; 137(5):572-5; discussion 575-6. PubMed ID: 11982471
[TBL] [Abstract][Full Text] [Related]
7. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
[TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence.
Takaki A; Yasunaka T; Yagi T
Int J Mol Sci; 2015 Jul; 16(8):17494-513. PubMed ID: 26263973
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
[TBL] [Abstract][Full Text] [Related]
10. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease.
Arslan M; Wiesner RH; Sievers C; Egan K; Zein NN
Liver Transpl; 2001 Apr; 7(4):314-20. PubMed ID: 11303291
[TBL] [Abstract][Full Text] [Related]
11. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis.
Angelico M; Di Paolo D; Trinito MO; Petrolati A; Araco A; Zazza S; Lionetti R; Casciani CU; Tisone G
Hepatology; 2002 Jan; 35(1):176-81. PubMed ID: 11786974
[TBL] [Abstract][Full Text] [Related]
12. Response to vaccination against hepatitis B virus with a schedule of four 40-μg doses in cirrhotic patients evaluated for liver transplantation: factors associated with a response.
Gutierrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martin JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1499-501. PubMed ID: 22841195
[TBL] [Abstract][Full Text] [Related]
13. Discontinuation of Hepatitis B Immunoglobulin by Long-term Hepatitis B Vaccine Inoculation in Preventing Hepatitis B Recurrence After Liver Transplantation.
Usui M; Sugimoto K; Kato H; Murata Y; Tanemura A; Kuriyama N; Azumi Y; Kishiwada M; Mizuno S; Sakurai H; Takei Y; Isaji S
Transplant Proc; 2016 May; 48(4):1179-83. PubMed ID: 27320582
[TBL] [Abstract][Full Text] [Related]
14. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
[TBL] [Abstract][Full Text] [Related]
15. Successful active immunization using a hepatitis B virus vaccination protocol for a recipient with hepatitis B core antibody-positive liver graft.
Ohno Y; Mita A; Ikegami T; Masuda Y; Urata K; Nakazawa Y; Kobayashi A; Miyagawa S
Transplant Proc; 2014 Apr; 46(3):721-5. PubMed ID: 24767333
[TBL] [Abstract][Full Text] [Related]
16. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of viral recurrence following liver transplantation for post-hepatitis B and B-delta cirrhosis].
Mentha G; Giostra E; Perrin L; Widmann JJ; Stelling MJ; Easton J; Morel P; Huber O; Le Coultre C; Bühler L
Schweiz Med Wochenschr; 1994 Apr; 124(15):637-41. PubMed ID: 8191267
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B Vaccination in Patients Receiving Oral Antiviral Therapy Without Hepatitis B Immunoglobulin After Liver Transplant.
Wong TCL; Fung JYY; Chok KSH; Cheung TT; Chan ACY; Dai WC; Ng KKC; Chan SC; Lo CM
Transplant Proc; 2018 Dec; 50(10):3681-3688. PubMed ID: 30577255
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of hepatitis B-antibody loss and a case report of
Sintusek P; Posuwan N; Wanawongsawad P; Jitraruch S; Poovorawan Y; Chongsrisawat V
World J Gastroenterol; 2018 Feb; 24(6):752-762. PubMed ID: 29456414
[TBL] [Abstract][Full Text] [Related]
20. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients.
Stärkel P; Stoffel M; Lerut J; Horsmans Y
Liver Transpl; 2005 Oct; 11(10):1228-34. PubMed ID: 16184571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
